William Yashar

7PUBLICATIONS
30CO-AUTHORS
Gene and molecular therapyOral medicine and pathologyBiological network analysisHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 06, 2026
PU.1 inhibition sensitizes stem-monocytic AML to BCL2 blockade.

William M Yashar, Itallia V Pacentine, Akram Taherinasab

|Jan 21, 2026
DDX41-Mutated AML: A Case Report and Perspectives.

William M Yashar, Christopher A Eide, Stephen E Kurtz

|Nov 21, 2023
A framework for considering prior information in network-based approaches to omics data analysis.

Julia Somers, Madeleine Fenner, Garth Kong

|Mar 28, 2023
Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.

William M Yashar, Brittany M Curtiss, Daniel J Coleman

|Mar 09, 2023
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development.

Sarah A Carratt, Garth L Kong, Cody Coblentz

|Dec 16, 2022
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors.

Theodore P Braun, Joseph Estabrook, Zachary Schonrock

Pageof 2